ArticleIntestinal research2021

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study

Yasuo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.